OM Stock Forecast 2025-2026
Distance to OM Price Targets
OM Price Momentum
10 Quality Stocks Worth Considering Now
Researching Outset (OM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on OM and similar high-potential opportunities.
Latest OM Stock Price Targets & Analyst Predictions
Based on our analysis of 11 Wall Street analysts, OM has a bullish consensus with a median price target of $15.00 (ranging from $12.00 to $45.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $11.01, the median forecast implies a 36.2% upside. This outlook is supported by 3 Buy, 2 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OM Analyst Ratings
OM Price Target Range
Latest OM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 7, 2025 | RBC Capital | Shagun Singh | Sector Perform | Reiterates | $3.00 |
| Aug 8, 2024 | TD Cowen | Joshua Jennings | Buy | Maintains | $3.00 |
| Aug 8, 2024 | RBC Capital | Shagun Singh | Sector Perform | Downgrade | $3.00 |
| Jun 21, 2024 | RBC Capital | Shagun Singh | Outperform | Upgrade | $6.00 |
| Apr 8, 2024 | BTIG | Maria Thibault | Buy | Initiates | $6.00 |
| Jan 12, 2024 | RBC Capital | Shagun Singh | Sector Perform | Downgrade | $6.00 |
| Dec 4, 2023 | Morgan Stanley | Drew Ranieri | Equal-Weight | Maintains | $5.50 |
| Nov 14, 2023 | Morgan Stanley | Drew Ranieri | Equal-Weight | Maintains | $5.00 |
| Oct 13, 2023 | Stifel | Rick Wise | Buy | Maintains | $6.00 |
| Oct 13, 2023 | RBC Capital | Shagun Singh | Outperform | Maintains | $17.00 |
| Oct 13, 2023 | B of A Securities | Travis Steed | Underperform | Downgrade | $3.00 |
| Aug 24, 2023 | Morgan Stanley | Drew Ranieri | Equal-Weight | Maintains | $19.00 |
| Aug 17, 2023 | RBC Capital | Shagun Singh | Outperform | Reiterates | $29.00 |
| Aug 17, 2023 | CL King | Kristen Stewart | Neutral | Initiates | $0.00 |
| Aug 3, 2023 | Morgan Stanley | Equal-Weight | Maintains | $0.00 | |
| May 31, 2023 | Morgan Stanley | Drew Ranieri | Equal-Weight | Maintains | $23.00 |
| May 15, 2023 | RBC Capital | Shagun Singh | Outperform | Reiterates | $29.00 |
| May 4, 2023 | RBC Capital | Shagun Singh | Outperform | Maintains | $29.00 |
| Jan 6, 2023 | Morgan Stanley | Drew Ranieri | Equal-Weight | Maintains | $27.00 |
| Nov 11, 2022 | RBC Capital | Shagun Singh | Outperform | Initiates | $23.00 |
Outset Medical Inc. (OM) Competitors
The following stocks are similar to Outset based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Outset Medical Inc. (OM) Financial Data
Outset Medical Inc. has a market capitalization of $195.12M with a P/E ratio of 0.0x. The company generates $113.69M in trailing twelve-month revenue with a -112.6% profit margin.
Revenue growth is -3.4% quarter-over-quarter, while maintaining an operating margin of -55.3% and return on equity of -171.0%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Outset Medical Inc. (OM) Business Model
About Outset Medical Inc.
Develops innovative dialysis solutions.
Outset Medical Inc. generates revenue through the commercialization of its flagship product, the Tablo Hemodialysis System, which simplifies and enhances the dialysis treatment process. By offering a comprehensive solution that combines water purification and dialysate production, the company caters to both medical facilities and home care settings, thereby expanding its market reach and accessibility.
The company is headquartered in the United States and is focused on transforming the dialysis sector to improve patient quality of life. With a commitment to innovation, Outset Medical aims to meet the increasing demand for effective and scalable renal care solutions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
480
CEO
Ms. Leslie L. Trigg
Country
United States
IPO Year
2020
Website
www.outsetmedical.comOutset Medical Inc. (OM) Latest News & Analysis
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know
17 days agoOutset Medical (OM) has a consensus price target indicating a potential 188.6% upside. Earnings estimate revisions show an upward trend, suggesting possible near-term gains.
The high price target suggests strong growth potential for Outset Medical (OM), while rising earnings estimates indicate possible near-term gains, attracting investor interest.
Outset Medical, Inc. will execute a one-for-fifteen reverse stock split effective March 20, 2025. The stock will continue to trade under the symbol OM on Nasdaq.
Outset Medical's reverse stock split indicates a strategy to boost share price and attract institutional investors, potentially signaling financial restructuring or improving market perception.
Outset Medical (OM) shows a hammer chart pattern, suggesting potential support after recent losses, alongside rising earnings estimate revisions, indicating a possible trend reversal.
Outset Medical's hammer chart pattern suggests potential price recovery, while rising earnings estimates indicate improving fundamentals, signaling a possible upward trend for the stock.
In 2025, Bitcoin reached $100,000 in December but has since struggled to deliver on expectations, showing signs of underperformance.
Bitcoin's failure to meet high expectations in 2025 may signal waning investor confidence, potentially leading to decreased demand and further price volatility.
Outset Medical, Inc. (Nasdaq: OM) will present at the TD Cowen Health Care conference on March 4, 2025, at 2:30 p.m. The company focuses on innovative dialysis technology.
Outset Medical's technology could disrupt the dialysis market, impacting future revenue. A presentation at a major conference may attract investor interest and signal potential growth.
Outset Medical: Profitability Path Brightens
2 months agoOutset Medical reported Q4 earnings on Feb. 19, with revenue of $29.5 million, surpassing expectations of $28 million, indicating strong performance despite market challenges.
Outset Medical's Q4 earnings beat expectations, with revenue growth signaling strong performance and resilience, potentially boosting investor confidence and stock value.
Frequently Asked Questions About OM Stock
What is Outset Medical Inc.'s (OM) stock forecast for 2025?
Based on our analysis of 11 Wall Street analysts, Outset Medical Inc. (OM) has a median price target of $15.00. The highest price target is $45.00 and the lowest is $12.00.
Is OM stock a good investment in 2025?
According to current analyst ratings, OM has 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $11.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OM stock?
Wall Street analysts predict OM stock could reach $15.00 in the next 12 months. This represents a 36.2% increase from the current price of $11.01. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Outset Medical Inc.'s business model?
Outset Medical Inc. generates revenue through the commercialization of its flagship product, the Tablo Hemodialysis System, which simplifies and enhances the dialysis treatment process. By offering a comprehensive solution that combines water purification and dialysate production, the company caters to both medical facilities and home care settings, thereby expanding its market reach and accessibility.
What is the highest forecasted price for OM Outset Medical Inc.?
The highest price target for OM is $45.00 from at , which represents a 308.7% increase from the current price of $11.01.
What is the lowest forecasted price for OM Outset Medical Inc.?
The lowest price target for OM is $12.00 from at , which represents a 9.0% increase from the current price of $11.01.
What is the overall OM consensus from analysts for Outset Medical Inc.?
The overall analyst consensus for OM is bullish. Out of 11 Wall Street analysts, 3 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $15.00.
How accurate are OM stock price projections?
Stock price projections, including those for Outset Medical Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.